On this page
⚠ Educational content only Not medical or genetic advice. Speak with a healthcare provider or genetic counsellor before acting on anything here.

RPS6KA3

ribosomal protein S6 kinase A3

The *RPS6KA3* gene provides instructions for a protein critical in cell signalling pathways, particularly within the brain, and is associated with conditions like Coffin-Lowry syndrome. The *RPS6KA3* gene encodes a ribosomal S6 kinase protein involved in regulating gene activity and various cellular processes, including cell growth, differentiation, and programmed cell death.

Chromosome Xp22.12 Polygenic HGNC:10432 Tier C
RPS6KA3 Xp22.12 p arm q arm X

RPS6KA3 is located on the short (p) arm of chromosome X, at band Xp22.12. Arm ratio per GRCh38 - banding schematic.

Explore chromosome X in the library →

Available at Jeen Health

Clinical tests that include this

Overview

The *RPS6KA3* gene, also known as ribosomal protein S6 kinase A3, is a crucial component in cellular signalling cascades. It encodes a protein belonging to the ribosomal S6 kinase (RSK) family, which helps regulate the activity of certain genes. This regulation is essential for fundamental cellular processes such as cell growth, division (proliferation), specialisation (differentiation), and programmed cell death (apoptosis).

The protein produced by *RPS6KA3* is particularly important for neurological function. It participates in signalling pathways necessary for cognitive processes like learning and the formation of long-term memories. Additionally, it contributes to the survival and maintenance of nerve cells in the brain, underscoring its significance in neurological health.

What the gene does

The *RPS6KA3* gene instructs the cell to produce a protein that functions as a ribosomal S6 kinase. These kinases are part of a larger family of proteins that act as key regulators within intracellular signalling pathways. They contribute to regulating gene expression and are involved in various cellular activities, including controlling cell proliferation, guiding cell differentiation, and initiating apoptosis.

Within the brain, the *RPS6KA3* protein plays a significant role in pathways essential for neuronal health and cognitive function. It is involved in processes that facilitate learning, the consolidation of long-term memories, and ensuring the viability of nerve cells. Dysregulation of this protein can therefore impact normal brain development and function.

Video: Genetics 101

Chromosome location

The *RPS6KA3* gene is situated on the short arm of the X chromosome at position Xp22.12. As a gene located on the X chromosome, its inheritance pattern can differ between sexes, with males typically being more severely affected by X-linked conditions due to having only one X chromosome.

Protein structure

The *RPS6KA3* protein consists of 740 amino acids and features a complex domain architecture crucial for its kinase activity and regulatory functions. It includes a Disordered region spanning amino acids 1-38, which may be involved in protein-protein interactions or regulatory mechanisms. The protein also contains two distinct kinase domains: Protein kinase 1 (amino acids 68-327) and Protein kinase 2 (amino acids 422-679), both essential for its enzymatic function. An AGC-kinase C-terminal domain is also present from amino acids 328-397.

Domain map · 740 amino acids
Protein kinase 1 (68-327)AGC-kinase C-terminal (328-397)Protein kinase 2 (422-679)Protein kinase 168-327AGC-kinase C-terminal328-397Protein kinase 2422-6791~370740
Domain - independent functional unit
🧬 Explore 3D structure on AlphaFold
UniProt:P51812Length:740 aaStructure:AlphaFold

Key variants

Variants within the *RPS6KA3* gene can affect the structure and function of the encoded protein, leading to a spectrum of developmental and neurological conditions. These variants can include changes that insert or delete genetic material, or alter the way the gene's instructions are processed. Such changes can severely reduce or eliminate the protein's activity, impacting critical cellular pathways.

The table below shows the top 10 pathogenic or likely-pathogenic variants currently classified in ClinVar for RPS6KA3.
View all on ClinVar →

Sample of pathogenic variants

10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.

Variant (HGVS) Protein change Classification Evidence Associated condition
c.1540C>T
single nucleotide variant
p.Arg514Ter Pathogenic ★★☆☆ RPS6KA3-related disorder
c.1603-5A>G
single nucleotide variant
- Pathogenic/Likely pathogenic ★★☆☆ Coffin-Lowry syndrome
c.212T>G
single nucleotide variant
p.Leu71Ter Pathogenic/Likely pathogenic ★★☆☆ Coffin-Lowry syndrome
c.2185C>T
single nucleotide variant
p.Arg729Trp Pathogenic/Likely pathogenic ★★☆☆ Coffin-Lowry syndrome
c.262dup
Duplication
p.Ile88fs Pathogenic ★★☆☆ Coffin-Lowry syndrome
c.334C>T
single nucleotide variant
p.Arg112Ter Pathogenic ★★☆☆ Coffin-Lowry syndrome
c.727C>T
single nucleotide variant
p.Arg243Ter Pathogenic ★★☆☆ Coffin-Lowry syndrome
c.817C>T
single nucleotide variant
p.Arg273Ter Pathogenic ★★☆☆ Coffin-Lowry syndrome
c.889_890del
Microsatellite
p.Leu298fs Pathogenic/Likely pathogenic ★★☆☆ RPS6KA3-related disorder
c.898C>T
single nucleotide variant
p.Arg300Ter Pathogenic ★★☆☆ RPS6KA3-related disorder

Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.

Associated conditions

Pathogenic variants in the *RPS6KA3* gene are primarily associated with Coffin-Lowry syndrome, an X-linked disorder characterised by intellectual disability and skeletal abnormalities. Over 125 different variants within this gene have been identified in individuals with Coffin-Lowry syndrome. Additionally, some *RPS6KA3* variants are linked to X-linked intellectual disability in individuals who do not exhibit the full range of features typically seen in Coffin-Lowry syndrome.

UK clinical status

The *RPS6KA3* gene is recognised within the NHS Genomic Medicine Service due to its clinical significance. It is part of several PanelApp green listings, indicating strong evidence for its association with disease. These include panels for DDG2P, Foetal anomalies (R21), Hydrocephalus (R86), Intellectual disability, and IUGR and IGF abnormalities.

Frequently asked questions

What is the primary function of the *RPS6KA3* gene?

The *RPS6KA3* gene provides instructions for a protein that belongs to the ribosomal S6 kinase family. This protein plays a vital role in cell signalling pathways, regulating gene activity and influencing processes such as cell growth, differentiation, and nerve cell survival, particularly in the brain.

Which condition is most commonly associated with *RPS6KA3* gene variants?

The *RPS6KA3* gene is most commonly associated with Coffin-Lowry syndrome, an X-linked inherited condition characterised by intellectual disability and distinctive skeletal features. Variants in this gene can severely reduce or eliminate the protein's function.

How does *RPS6KA3* relate to brain function?

The protein encoded by *RPS6KA3* is crucial for brain function, participating in cell signalling pathways that are essential for learning, the formation of long-term memories, and the survival of nerve cells. Disruptions to this gene can therefore impact neurological development and cognitive abilities.

References

  1. Raymond FL. X linked mental retardation: a clinical guide. Journal of medical genetics. 2006. PMID: 16118346
  2. Delaunoy JP, Dubos A, Marques Pereira P. Identification of novel mutations in the RSK2 gene (RPS6KA3) in patients with Coffin-Lowry syndrome. Clinical genetics. 2006. PMID: 16879200
  3. Field M, Tarpey P, Boyle J. Mutations in the RSK2(RPS6KA3) gene cause Coffin-Lowry syndrome and nonsyndromic X-linked mental retardation. Clinical genetics. 2006. PMID: 17100996
  4. Guimiot F, Delezoide AL, Hanauer A. Expression of the RSK2 gene during early human development. Gene expression patterns : GEP. 2004. PMID: 14678837
  5. Zeniou M, Gattoni R, Hanauer A. Delineation of the mechanisms of aberrant splicing caused by two unusual intronic mutations in the RSK2 gene involved in Coffin-Lowry syndrome. Nucleic acids research. 2004. PMID: 14973203
  6. Hanauer A, Young ID. Coffin-Lowry syndrome: clinical and molecular features. Journal of medical genetics. 2002. PMID: 12362025
  7. Zeniou M, Ding T, Trivier E. Expression analysis of RSK gene family members: the RSK2 gene, mutated in Coffin-Lowry syndrome, is prominently expressed in brain structures essential for cognitive function and learning. Human molecular genetics. 2002. PMID: 12393804
  8. Delaunoy J, Abidi F, Zeniou M. Mutations in the X-linked RSK2 gene (RPS6KA3) in patients with Coffin-Lowry syndrome. Human mutation. 2001. PMID: 11180593
Educational content. This page is not medical or genetic advice, is not individually reviewed by a clinician for each reader, and should not replace a consultation with a qualified healthcare professional or genetic counsellor. If you are considering genetic testing or acting on a test result, book a consultation.
Data sources Last updated 4 October 2026. Content compiled from HGNC · MedlinePlus Genetics · ClinGen · Genomics England PanelApp · NHS National Genomic Test Directory · ClinVar · UniProt · AlphaFold .